Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Scientists at AbboMax developed antibodies to study Parkinson's diseaseA panel of PINK1 and Parkin antibodies was developed at Abbomax to investigate Parkinson's disease (PD). These phosphospecific and paired antibodies would be the useful tools for studies of PINK/Parkin pathways and signaling in PD.
By: AbboMax, Inc. AbboMax has been involved in researching, developing and manufacturing of high performance antibodies and related immunoassay reagents for many years. We specialize in antibody and assay development, provide high-quality custom service and products. AbboMax is focusing on phosphospecific antibodies, IHC grade monoclonal antibodies, FFPE cell pellets slides, tissue/cell blocks and CRO services including recombinant protein, custom bio-conjugation, antibody fragmentation, Antibody Epitope Mapping (AEM), scale-up process for pharmaceutical companies and CLIA labs. All the manufacturing activities are performed in our the Silicon Valley Core Facility located in San Jose, California. We can provide bulk quantities at economical prices, and guarantee a fast delivery with high quality products. Contact: Natasha Raysberg, Ph.D. www.abbomax.com info@abbomax.com Phone 408-573- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|